(WASHINGTON EXAMINER) – The United States government could save billions of healthcare dollars if it purchased generic drugs at the prices offered by Mark Cuban’s new online pharmacy that was launched this year.
In a comparison between Medicare’s spending in 2020 and the prices of Cuban’s Cost Plus Drug Company, researchers found that Medicare could have saved $3.6 billion, according to new research from Brigham and Women’s Hospital and Harvard Medical School published Monday in the journal Annals of Internal Medicine.
Dr. Hussain Saleem Lalani, a researcher at Brigham and Women’s Hospital in Boston and the study’s lead author, said that the study “does show that Medicare is overpaying for some of the generic drugs.”
